NRX Sale Purchase Of Stock from 2010 to 2025

NRXP Stock  USD 2.06  0.06  2.83%   
NRX Pharmaceuticals Sale Purchase Of Stock yearly trend continues to be relatively stable with very little volatility. Sale Purchase Of Stock is likely to grow to about -22.5 M this year. During the period from 2010 to 2025, NRX Pharmaceuticals Sale Purchase Of Stock destribution of quarterly values had range of 110.8 M from its regression line and mean deviation of  49,562,166. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2010-12-31
Previous Quarter
-23.7 M
Current Value
-22.5 M
Quarterly Volatility
51.4 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NRX Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NRX Pharmaceuticals' main balance sheet or income statement drivers, such as Interest Income of 372.8 K, Interest Expense of 131.1 K or Selling General Administrative of 20.3 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. NRX financial statements analysis is a perfect complement when working with NRX Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NRX Pharmaceuticals Correlation against competitors.
To learn how to invest in NRX Stock, please use our How to Invest in NRX Pharmaceuticals guide.

Latest NRX Pharmaceuticals' Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of NRX Pharmaceuticals over the last few years. It is NRX Pharmaceuticals' Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NRX Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Slightly volatile
   Sale Purchase Of Stock   
       Timeline  

NRX Sale Purchase Of Stock Regression Statistics

Arithmetic Mean20,462,934
Geometric Mean44,587,792
Coefficient Of Variation251.34
Mean Deviation49,562,166
Median70,025,100
Standard Deviation51,431,247
Sample Variance2645.2T
Range110.8M
R-Value(0.83)
Mean Square Error859.9T
R-Squared0.70
Significance0.000058
Slope(9,016,123)
Total Sum of Squares39677.6T

NRX Sale Purchase Of Stock History

2025-22.5 M
2024-23.7 M
2020-26.3 M
2018-40.7 M

About NRX Pharmaceuticals Financial Statements

NRX Pharmaceuticals shareholders use historical fundamental indicators, such as Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Although NRX Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. The changes in NRX Pharmaceuticals' assets and liabilities, for example, are also reflected in the revenues and expenses on on NRX Pharmaceuticals' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Sale Purchase Of Stock-23.7 M-22.5 M

Additional Tools for NRX Stock Analysis

When running NRX Pharmaceuticals' price analysis, check to measure NRX Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NRX Pharmaceuticals is operating at the current time. Most of NRX Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NRX Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NRX Pharmaceuticals' price. Additionally, you may evaluate how the addition of NRX Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.